en
Doctoral thesis
Open access
English

HIV drug resistance and third line treatment outcomes in patients failing: Protease Inhibitor based second-line antiretroviral therapy in Zimbabwe

Defense date2020-10-23
Abstract

Introduction: We set out to assess the distribution of HIV drug resistance mutations and their risk factors in patients failing 2nd line ART and to determine treatment outcomes among patients receiving 3rd line ART in Zimbabwe. Methods: This work was done in collaboration with the Zimbabwe Ministry of Health through the AIDS and TB program. Routinely collected program data was analysed and reported. Results: The following manuscripts were published in peer reviewed journals: 1. HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe 2. Zimbabwe's National Third-Line Antiretroviral Therapy Program: Cohort Description and Treatment Outcomes 3. A case report of untreatable HIV infection in Harare, Zimbabwe Conclusion: Our findings demonstrate that poor adherence is the major cause of second-line ART failure. Access to HIV genotyping in Zimbabwe is low and may be a barrier to effective diagnosis of second-line ART failure and inappropriate switches to third-line ART.

eng
Keywords
  • HIV Drug Resistance
  • Third-line antiretroviral therapy
  • Zimbabwe
Research group
Citation (ISO format)
CHIMBETETE, Cleophas. HIV drug resistance and third line treatment outcomes in patients failing: Protease Inhibitor based second-line antiretroviral therapy in Zimbabwe. 2020. doi: 10.13097/archive-ouverte/unige:152657
Main files (1)
Thesis
accessLevelPublic
Identifiers
379views
182downloads

Technical informations

Creation06/21/2021 9:06:00 PM
First validation06/21/2021 9:06:00 PM
Update time06/20/2023 11:16:41 AM
Status update06/20/2023 11:16:41 AM
Last indexation05/06/2024 7:46:36 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack